SAIK ANDREW (EVP & Chief Financial Officer) reported 1 transaction at INTERCEPT PHARMACEUTICALS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 9/23/2022ACC: 0001104659-22-102662
Officer· EVP & Chief Financial Officer
Since Jun 2021
-908.00
Net shares
Net seller
$13.5K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
908.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−908.00
Price / share
$14.85
Trade value
$13.48K
% of position
1.5%
9/21/2022
58.82K→57.92K
Total
Net shares
−908.00
Net value
-$13.48K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/21/2022 | F · Tax Withholding | −908.00 | $14.85 | $13.48K | 1.5% | 58.82K | 57.92K |
| Total | −908.00 | -$13.48K | ||||||
Derivative Transactions0
No derivative transactions reported